Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Moodys
McKinsey
Harvard Business School
Baxter

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NDC 62175-0487

See Plans and Pricing

« Back to Dashboard

Average Pharmacy Cost for 62175-0487

Drug Name NDC Price/Unit ($) Unit Date
VERAPAMIL ER PM 300 MG CAPSULE 62175-0487-37 6.73586 EACH 2019-09-18
VERAPAMIL ER PM 300 MG CAPSULE 62175-0487-37 6.73015 EACH 2019-08-21
VERAPAMIL ER PM 300 MG CAPSULE 62175-0487-37 5.82211 EACH 2019-04-17
VERAPAMIL ER PM 300 MG CAPSULE 62175-0487-37 1.56823 EACH 2019-01-23
VERAPAMIL ER PM 300 MG CAPSULE 62175-0487-37 1.85854 EACH 2018-12-19
VERAPAMIL ER PM 300 MG CAPSULE 62175-0487-37 1.50506 EACH 2018-11-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 62175-0487

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
VERAPAMIL HCL 300MG CAP,SA Kremers Urban Pharmaceuticals, Inc 62175-0487-37 100 40.74 0.40740 2018-03-01 - 2023-02-28 FSS
VERAPAMIL HCL 300MG CAP,SA Kremers Urban Pharmaceuticals, Inc 62175-0487-37 100 53.86 0.53860 2019-01-01 - 2023-02-28 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
AstraZeneca
Express Scripts
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.